<?xml version="1.0" encoding="UTF-8"?>
<gtr:projectOverview xmlns:gtr="http://gtr.ukri.org/api"><gtr:projectComposition><gtr:collaborations/><gtr:leadResearchOrganisation url="http://gtr.ukri.org:80/organisation/318B5D98-4CB4-4B10-A876-08FC93071A56"><gtr:id>318B5D98-4CB4-4B10-A876-08FC93071A56</gtr:id><gtr:name>King's College London</gtr:name><gtr:department>Unlisted</gtr:department><gtr:address><gtr:line1>Capital House</gtr:line1><gtr:line2>2nd Floor, Guys Campus</gtr:line2><gtr:line3>42 Weston Street</gtr:line3><gtr:line4>London</gtr:line4><gtr:postCode>SE1 3QD</gtr:postCode><gtr:region>London</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:typeInd>RO</gtr:typeInd></gtr:leadResearchOrganisation><gtr:organisationRoles><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/318B5D98-4CB4-4B10-A876-08FC93071A56"><gtr:id>318B5D98-4CB4-4B10-A876-08FC93071A56</gtr:id><gtr:name>King's College London</gtr:name><gtr:address><gtr:line1>Capital House</gtr:line1><gtr:line2>2nd Floor, Guys Campus</gtr:line2><gtr:line3>42 Weston Street</gtr:line3><gtr:line4>London</gtr:line4><gtr:postCode>SE1 3QD</gtr:postCode><gtr:region>London</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>LEAD_RO</gtr:name></gtr:role></gtr:roles></gtr:organisationRole></gtr:organisationRoles><gtr:personRoles><gtr:personRole url="http://gtr.ukri.org:80/person/D52721D0-AA27-4B11-BFBF-39E5E5F2C29E"><gtr:id>D52721D0-AA27-4B11-BFBF-39E5E5F2C29E</gtr:id><gtr:firstName>Agamemnon</gtr:firstName><gtr:surname>Grigoriadis</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.ukri.org:80/person/5B408C22-EAA2-408F-9769-205BDDDF188F"><gtr:id>5B408C22-EAA2-408F-9769-205BDDDF188F</gtr:id><gtr:firstName>C</gtr:firstName><gtr:surname>Mathew</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.ukri.org:80/person/72C59BEB-6A94-4796-A023-E21CC651A41C"><gtr:id>72C59BEB-6A94-4796-A023-E21CC651A41C</gtr:id><gtr:firstName>Swee Lay</gtr:firstName><gtr:surname>Thein</gtr:surname><gtr:orcidId>0000-0002-9835-6501</gtr:orcidId><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.ukri.org:80/person/3611393C-B14F-4035-B03B-9F07C2EAAD6F"><gtr:id>3611393C-B14F-4035-B03B-9F07C2EAAD6F</gtr:id><gtr:firstName>Gillian</gtr:firstName><gtr:surname>Bates</gtr:surname><gtr:orcidId>0000-0002-4041-6305</gtr:orcidId><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.ukri.org:80/person/1BE255AB-00BF-4AA3-9E28-22D1A5562980"><gtr:id>1BE255AB-00BF-4AA3-9E28-22D1A5562980</gtr:id><gtr:firstName>Michael</gtr:firstName><gtr:surname>Antoniou</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.ukri.org:80/person/96BDA244-6D61-4208-AC6D-F881F4BDFF47"><gtr:id>96BDA244-6D61-4208-AC6D-F881F4BDFF47</gtr:id><gtr:firstName>Jerry</gtr:firstName><gtr:surname>Lanchbury</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.ukri.org:80/person/37498F01-70DA-4C3B-BB71-27139DC6BDF5"><gtr:id>37498F01-70DA-4C3B-BB71-27139DC6BDF5</gtr:id><gtr:firstName>philippa</gtr:firstName><gtr:surname>Francis-West</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.ukri.org:80/person/954E1719-7EB6-4B83-979B-40E0DCB02AF3"><gtr:id>954E1719-7EB6-4B83-979B-40E0DCB02AF3</gtr:id><gtr:firstName>Paul</gtr:firstName><gtr:surname>Sharpe</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.ukri.org:80/person/C9B069BD-5D15-43B4-B0D6-6A64211DC850"><gtr:id>C9B069BD-5D15-43B4-B0D6-6A64211DC850</gtr:id><gtr:firstName>Ellen</gtr:firstName><gtr:surname>Solomon</gtr:surname><gtr:roles><gtr:role><gtr:name>PRINCIPAL_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.ukri.org:80/person/2C8449A4-22C8-4857-A9A3-BF4A17360F53"><gtr:id>2C8449A4-22C8-4857-A9A3-BF4A17360F53</gtr:id><gtr:firstName>Cathryn</gtr:firstName><gtr:surname>Lewis</gtr:surname><gtr:orcidId>0000-0002-8249-8476</gtr:orcidId><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole></gtr:personRoles><gtr:project url="http://gtr.ukri.org:80/projects?ref=G9800001"><gtr:id>AE79CABF-E158-4EEC-A8C1-5A03011FBFEA</gtr:id><gtr:title>Genetic Approaches to Human Disease</gtr:title><gtr:status>Closed</gtr:status><gtr:grantCategory>Research Grant</gtr:grantCategory><gtr:grantReference>G9800001</gtr:grantReference><gtr:abstractText>The Co-op Group continues to apply modern molecular genetic methods to increase our understanding of human disorders, and to use this knowledge to improve the treatment available to patients with these diseases. Thanks to the Human Genome Mapping Project, we now know the location of many of the genes responsible for genetic disorders, such as muscular dystrophy, haemophilia and cystic fibrosis, and can isolate and study them. However, there are also many complex disorders (caused by interactions between genes ? often more than one - the environment and other factors), such as a susceptibility to heart disease, cancer or diabetes, about which we still know very little. This Co-op Group aims to locate genes involved in these disorders, through the use of new laboratory and statistical techniques. The Co-op Group also focuses on understanding the function of these genes once they are known. This is done partly by growing and studying cell lines containing particular genes. However, the gene being examined may affect the whole body, or a whole organ, in which case it cannot be studied in individual cells, and in these cases it may be necessary to study animal models. We have the ability and expertise necessary to analyse such genes ? and, in particular, the altered (mutant) genes which may be found in the disease state ? in mouse models. These studies increase our knowledge of the ways in which genes can malfunction, leading to disease, and we are also particularly interested in, and involved in, developing ways of correcting such disorders. We are already involved in clinical trials of diagnostics and therapeutics, based upon our discoveries.</gtr:abstractText><gtr:technicalSummary>This proposal is for the renewal of our Co-operative Group and core support. The Co-op is built upon the use of common genetic, genomic and functional approaches to the understanding of human genetic and developmental disease. The Group includes members from the GKT Dental Institute (Department of Craniofacial Development) and the GKT School of Medicine (Departments of Medical and Molecular Genetics, Haematology and Rheumatology). Shared expertise and common approaches serve to bring the Group together with the enormous added value of communal facilities. The four main approaches are: (1) Analysis of Complex Genetic Disease including theoretical aspects of genome searches, inflammatory bowel disease, breast cancer, auto-immune disease, sickle cell disease/thalassemia (Lewis, Mathew, Solomon, Lanchbury, Thein) and include collaboration with the MRC HGMP Resource Centre); (2) Animal Models for craniofacial development including collaborations with the ENU Mutagenesis screen at the MRC Unit at Harwell, Huntington?s Disease, Xenopus and chick systems for musculoskeletal development, mouse modes for oculopharyngeal muscular dystrophy, mouse knock-outs involving neuromuscular development, mouse models for Acute Promyeloctyic Leukaemias, and ES cell systems for studying bone cell biology (Sharpe, Bates, Solomon, Frances-West, Antoniou, Grigoriadis); (3) Functional Genetic Analysis using communal facilities for microarray expression and bioinformatics, laser microdissection, organ culture methods, laser scanning confocal microscopy, and proteomics (Mathew, Solomon, Sharpe, Thein, Antoniou, Grigorioadis, Bates); (4) Experimental Therapeutics and Clinical Trials, including the development of gene therapy technologies, preclinical trials for Huntington?s Disease, and participation in the MRC AML15 trial for acute myeloid leukaemia (Antoniou, Bates, Solomon).</gtr:technicalSummary><gtr:fund><gtr:end>2009-06-29</gtr:end><gtr:funder url="http://gtr.ukri.org:80/organisation/C008C651-F5B0-4859-A334-5F574AB6B57C"><gtr:id>C008C651-F5B0-4859-A334-5F574AB6B57C</gtr:id><gtr:name>MRC</gtr:name></gtr:funder><gtr:start>1999-03-01</gtr:start><gtr:type>INCOME_ACTUAL</gtr:type><gtr:valuePounds>575717</gtr:valuePounds></gtr:fund><gtr:output><gtr:artisticAndCreativeProductOutputs/><gtr:collaborationOutputs/><gtr:disseminationOutputs/><gtr:exploitationOutputs/><gtr:furtherFundingOutputs/><gtr:impactSummaryOutputs/><gtr:intellectualPropertyOutputs/><gtr:otherResearchOutputs/><gtr:policyInfluenceOutputs/><gtr:productOutputs/><gtr:researchDatabaseAndModelOutputs/><gtr:researchMaterialOutputs/><gtr:softwareAndTechnicalProductOutputs/><gtr:spinOutOutputs/></gtr:output><gtr:publications><gtr:publication><gtr:id>41456C30-BC10-4081-8957-335DE8B0BE5A</gtr:id><gtr:title>Neighbor of Brca1 gene (Nbr1) functions as a negative regulator of postnatal osteoblastic bone formation and p38 MAPK activity.</gtr:title><gtr:parentPublicationTitle>Proceedings of the National Academy of Sciences of the United States of America</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/091af23f12017c8f8784e67acda8b94b"><gtr:id>091af23f12017c8f8784e67acda8b94b</gtr:id><gtr:otherNames>Whitehouse CA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0027-8424</gtr:issn><gtr:outcomeId>VAi6wEfefEE</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>2A184CD1-A5E5-4C17-9E5E-022D4CD3AAF5</gtr:id><gtr:title>Evaluation of the benzothiazole aggregation inhibitors riluzole and PGL-135 as therapeutics for Huntington's disease.</gtr:title><gtr:parentPublicationTitle>Neurobiology of disease</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/5cd949cec8c8174e368cb8ea8956273d"><gtr:id>5cd949cec8c8174e368cb8ea8956273d</gtr:id><gtr:otherNames>Hockly E</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2006-01-01</gtr:date><gtr:issn>0969-9961</gtr:issn><gtr:outcomeId>MuBX44GjD5X</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>B2E8406D-BA6D-4534-874A-814DF5037C09</gtr:id><gtr:title>Sex stratification of an inflammatory bowel disease genome search shows male-specific linkage to the HLA region of chromosome 6.</gtr:title><gtr:parentPublicationTitle>European journal of human genetics : EJHG</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/08112693a12b70debb270f3297d29147"><gtr:id>08112693a12b70debb270f3297d29147</gtr:id><gtr:otherNames>Fisher SA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2002-01-01</gtr:date><gtr:issn>1018-4813</gtr:issn><gtr:outcomeId>KAPG1EZeAtv</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>92DC4DA4-7224-4ADE-A5C8-88A1058404BD</gtr:id><gtr:title>Suberoylanilide hydroxamic acid, a histone deacetylase inhibitor, ameliorates motor deficits in a mouse model of Huntington's disease.</gtr:title><gtr:parentPublicationTitle>Proceedings of the National Academy of Sciences of the United States of America</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/5cd949cec8c8174e368cb8ea8956273d"><gtr:id>5cd949cec8c8174e368cb8ea8956273d</gtr:id><gtr:otherNames>Hockly E</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2003-01-01</gtr:date><gtr:issn>0027-8424</gtr:issn><gtr:outcomeId>T8Pjq3FJEsp</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>58DD94DE-BEA5-47BE-88DB-2487473D2428</gtr:id><gtr:title>Standardization and statistical approaches to therapeutic trials in the R6/2 mouse.</gtr:title><gtr:parentPublicationTitle>Brain research bulletin</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/5cd949cec8c8174e368cb8ea8956273d"><gtr:id>5cd949cec8c8174e368cb8ea8956273d</gtr:id><gtr:otherNames>Hockly E</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2003-01-01</gtr:date><gtr:issn>0361-9230</gtr:issn><gtr:outcomeId>rVZ7FCaCK4f</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>2206CD3F-F406-4EDB-AD66-22EDCCD85F3F</gtr:id><gtr:title>Transformation of tooth type induced by inhibition of BMP signaling.</gtr:title><gtr:parentPublicationTitle>Science (New York, N.Y.)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/8e00b1631f9c73394b88448795f4d4a0"><gtr:id>8e00b1631f9c73394b88448795f4d4a0</gtr:id><gtr:otherNames>Tucker AS</gtr:otherNames></gtr:author></gtr:authors><gtr:date>1998-01-01</gtr:date><gtr:issn>0036-8075</gtr:issn><gtr:outcomeId>HrwPhGtiQZY</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>11C16F5D-ED57-4E90-8571-5BA35E5388B9</gtr:id><gtr:title>NBR1 interacts with fasciculation and elongation protein zeta-1 (FEZ1) and calcium and integrin binding protein (CIB) and shows developmentally restricted expression in the neural tube.</gtr:title><gtr:parentPublicationTitle>European journal of biochemistry</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/ebb040761593f479d43bd0c156530e56"><gtr:id>ebb040761593f479d43bd0c156530e56</gtr:id><gtr:otherNames>Whitehouse C</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2002-01-01</gtr:date><gtr:issn>0014-2956</gtr:issn><gtr:outcomeId>a1CgrDWzLXa</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>7A13E9B8-43AB-47C8-8E42-81FED3B816F2</gtr:id><gtr:title>Formation of polyglutamine inclusions in a wide range of non-CNS tissues in the HdhQ150 knock-in mouse model of Huntington's disease.</gtr:title><gtr:parentPublicationTitle>PloS one</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/e04c8a1a668abb2fef7a9ba84604e905"><gtr:id>e04c8a1a668abb2fef7a9ba84604e905</gtr:id><gtr:otherNames>Moffitt H</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>1932-6203</gtr:issn><gtr:outcomeId>fuJBdcPdbHv</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>77AB284C-45A1-439B-8954-31FEE180289F</gtr:id><gtr:title>Isolation and characterization of human and mouse ZIRTL, a member of the IRT1 family of transporters, mapping within the epidermal differentiation complex.</gtr:title><gtr:parentPublicationTitle>Genomics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/d2a00aa5b89d716f370813b31dab05cd"><gtr:id>d2a00aa5b89d716f370813b31dab05cd</gtr:id><gtr:otherNames>Lioumi M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>1999-01-01</gtr:date><gtr:issn>0888-7543</gtr:issn><gtr:outcomeId>pnfu9qC3nkB</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>3ED58F66-DD4D-4A02-9E4B-B5E7836CFFEA</gtr:id><gtr:title>Directed differentiation of hematopoietic precursors and functional osteoclasts from human ES and iPS cells.</gtr:title><gtr:parentPublicationTitle>Blood</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/ca05679e05432034e50f2bf03297416b"><gtr:id>ca05679e05432034e50f2bf03297416b</gtr:id><gtr:otherNames>Grigoriadis AE</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0006-4971</gtr:issn><gtr:outcomeId>PnX2DPFe6hq</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>B427DA44-15F2-4EC3-877E-B0589F37E5FF</gtr:id><gtr:title>Risk factors for detecting germline BRCA1 and BRCA2 founder mutations in Ashkenazi Jewish women with breast or ovarian cancer.</gtr:title><gtr:parentPublicationTitle>Journal of medical genetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/3bfa234d188842a2bacdac22dd75213e"><gtr:id>3bfa234d188842a2bacdac22dd75213e</gtr:id><gtr:otherNames>Hodgson SV</gtr:otherNames></gtr:author></gtr:authors><gtr:date>1999-01-01</gtr:date><gtr:issn>0022-2593</gtr:issn><gtr:outcomeId>oXez4v7uHVV</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>4169A541-B37E-46A2-B926-84C645501134</gtr:id><gtr:title>The contribution of NOD2 gene mutations to the risk and site of disease in inflammatory bowel disease.</gtr:title><gtr:parentPublicationTitle>Gastroenterology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/34c8dbd0117839d9f8197afe3fe15e33"><gtr:id>34c8dbd0117839d9f8197afe3fe15e33</gtr:id><gtr:otherNames>Cuthbert AP</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2002-01-01</gtr:date><gtr:issn>0016-5085</gtr:issn><gtr:outcomeId>owfSpMb2xxJ</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>21AD530D-0F3A-4E5C-A39D-AD9A5170A1E3</gtr:id><gtr:title>Proteolysis of mutant huntingtin produces an exon 1 fragment that accumulates as an aggregated protein in neuronal nuclei in Huntington disease.</gtr:title><gtr:parentPublicationTitle>The Journal of biological chemistry</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/1beaa99d5e16d4e7f1210cd930fe6d16"><gtr:id>1beaa99d5e16d4e7f1210cd930fe6d16</gtr:id><gtr:otherNames>Landles C</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0021-9258</gtr:issn><gtr:outcomeId>pm_540e17de17de46377</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>8F5948EE-BAB6-40B8-9CCC-47FDBF05565A</gtr:id><gtr:title>Meta-analysis of four rheumatoid arthritis genome-wide linkage studies: confirmation of a susceptibility locus on chromosome 16.</gtr:title><gtr:parentPublicationTitle>Arthritis and rheumatism</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/08112693a12b70debb270f3297d29147"><gtr:id>08112693a12b70debb270f3297d29147</gtr:id><gtr:otherNames>Fisher SA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2003-01-01</gtr:date><gtr:issn>0004-3591</gtr:issn><gtr:outcomeId>dey4yFiT43e</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>FF3979D2-5284-49C1-B142-623135D7EEF5</gtr:id><gtr:title>Acquired FANCA dysfunction and cytogenetic instability in adult acute myelogenous leukemia.</gtr:title><gtr:parentPublicationTitle>Blood</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/a24eb75e95d10935561e4e382f444aee"><gtr:id>a24eb75e95d10935561e4e382f444aee</gtr:id><gtr:otherNames>Lensch MW</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2003-01-01</gtr:date><gtr:issn>0006-4971</gtr:issn><gtr:outcomeId>Y22HgF41X4V</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>59F24D9E-62BC-4EC9-AD36-8005A642E7D1</gtr:id><gtr:title>Association between insertion mutation in NOD2 gene and Crohn's disease in German and British populations.</gtr:title><gtr:parentPublicationTitle>Lancet (London, England)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/f5e40edaaf6bec4c51cf779986f95d90"><gtr:id>f5e40edaaf6bec4c51cf779986f95d90</gtr:id><gtr:otherNames>Hampe J</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2001-01-01</gtr:date><gtr:issn>0140-6736</gtr:issn><gtr:outcomeId>KnrW59ozih1</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>EF3BD06C-1933-49E9-8F7D-276E3D562C79</gtr:id><gtr:title>Gene defect in ectodermal dysplasia implicates a death domain adapter in development.</gtr:title><gtr:parentPublicationTitle>Nature</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/d49054fdc647fbf738b1f7473ae7c36c"><gtr:id>d49054fdc647fbf738b1f7473ae7c36c</gtr:id><gtr:otherNames>Headon DJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2001-01-01</gtr:date><gtr:issn>0028-0836</gtr:issn><gtr:outcomeId>rgUNdwyMMUG</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>BC8C1C3B-85A7-4429-8362-819DF8B7F0E6</gtr:id><gtr:title>Telomere shortening in Fanconi anaemia demonstrated by a direct FISH approach.</gtr:title><gtr:parentPublicationTitle>Cytogenetics and cell genetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/47ea252c1271c60d8b26bfd04b452e7b"><gtr:id>47ea252c1271c60d8b26bfd04b452e7b</gtr:id><gtr:otherNames>Hanson H</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2001-01-01</gtr:date><gtr:issn>0301-0171</gtr:issn><gtr:outcomeId>e1jawwiw1Z1</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>B27A94C1-3466-4B2D-B7D1-B1CF0BCBB7B2</gtr:id><gtr:title>Power of the TDT to detect association: effect of linkage disequilibrium between genetic markers and an unobserved disease mutation</gtr:title><gtr:parentPublicationTitle>GeneScreen</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/74dbd02d04db04a94db8b8e53d70ae7a"><gtr:id>74dbd02d04db04a94db8b8e53d70ae7a</gtr:id><gtr:otherNames>Lewis C</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2000-01-01</gtr:date><gtr:outcomeId>JUxFHNCKbQu</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>C737D449-4ECD-4BE7-93DC-FAE7B217F91D</gtr:id><gtr:title>DNA instability in postmitotic neurons.</gtr:title><gtr:parentPublicationTitle>Proceedings of the National Academy of Sciences of the United States of America</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/cbb9bd98281932ca9e81ab9f69b17054"><gtr:id>cbb9bd98281932ca9e81ab9f69b17054</gtr:id><gtr:otherNames>Gonitel R</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>0027-8424</gtr:issn><gtr:outcomeId>AdyfLmZ4sUz</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>44C7EF64-33C4-464E-8305-C836E2C1B347</gtr:id><gtr:title>Molecular cloning, chromosomal mapping, and developmental expression of a novel protein tyrosine phosphatase-like gene.</gtr:title><gtr:parentPublicationTitle>Genomics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/e4d8dc0b2579b0d90b2bff972118677b"><gtr:id>e4d8dc0b2579b0d90b2bff972118677b</gtr:id><gtr:otherNames>Uwanogho DA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>1999-01-01</gtr:date><gtr:issn>0888-7543</gtr:issn><gtr:outcomeId>ciBxhmmnNrm</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>B89F6A39-A957-429F-8E75-05B2FD210EE5</gtr:id><gtr:title>A putative role for c-Fos in the pathophysiology of Paget's disease.</gtr:title><gtr:parentPublicationTitle>Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/7bab7ae37b0292691abf557c788faf9e"><gtr:id>7bab7ae37b0292691abf557c788faf9e</gtr:id><gtr:otherNames>Beedles KE</gtr:otherNames></gtr:author></gtr:authors><gtr:date>1999-01-01</gtr:date><gtr:issn>0884-0431</gtr:issn><gtr:outcomeId>GSngESgBvBs</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>B2E64F99-9DEA-40BD-9259-FA5A74D223B9</gtr:id><gtr:title>Prospective minimal residual disease monitoring to predict relapse of acute promyelocytic leukemia and to direct pre-emptive arsenic trioxide therapy.</gtr:title><gtr:parentPublicationTitle>Journal of clinical oncology : official journal of the American Society of Clinical Oncology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/fa63804623afefe42d3849f6aead48b0"><gtr:id>fa63804623afefe42d3849f6aead48b0</gtr:id><gtr:otherNames>Grimwade D</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>0732-183X</gtr:issn><gtr:outcomeId>SSWbeaLkSHX</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>D354539C-2766-4FA4-A386-57F8DEA33E8D</gtr:id><gtr:title>Cell fate specification during calvarial bone and suture development.</gtr:title><gtr:parentPublicationTitle>Developmental biology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/8238ecdfc0b37d7f0110552f65041fe6"><gtr:id>8238ecdfc0b37d7f0110552f65041fe6</gtr:id><gtr:otherNames>Lana-Elola E</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2007-01-01</gtr:date><gtr:issn>0012-1606</gtr:issn><gtr:outcomeId>nCTR52HeZdw</gtr:outcomeId></gtr:publication></gtr:publications><gtr:identifiers><gtr:identifier type="RCUK">G9800001</gtr:identifier></gtr:identifiers><gtr:healthCategories><gtr:healthCategory><gtr:id>F3822669-BB5A-4BB4-BAE0-DCB9DE36E092</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>Generic Health Relevance</gtr:text></gtr:healthCategory></gtr:healthCategories><gtr:researchActivities><gtr:researchActivity><gtr:id>CF950C9A-DB16-4E23-8AEB-94548777BCA1</gtr:id><gtr:percentage>50</gtr:percentage><gtr:text>1.1  Normal biological development and functioning</gtr:text></gtr:researchActivity><gtr:researchActivity><gtr:id>1BF330A9-C7B5-49C5-B54B-CF4FAE6DF1D8</gtr:id><gtr:percentage>50</gtr:percentage><gtr:text>2.1  Biological and endogenous factors</gtr:text></gtr:researchActivity></gtr:researchActivities><gtr:researchSubjects/><gtr:researchTopics/><gtr:rcukProgrammes/></gtr:project></gtr:projectComposition></gtr:projectOverview>